Literature DB >> 30660860

Examining work-to-rest ratios to optimize upper body sprint interval training.

Michael B La Monica1, David H Fukuda2, Tristan M Starling-Smith2, Nicolas W Clark2, Jose Morales3, Jay R Hoffman2, Jeffrey R Stout2.   

Abstract

The objective was to compare the metabolic influence of varying work-to-rest ratios during upper body sprint interval training (SIT). Forty-two recreationally-trained men were randomized into a training group [10 s work - 2 min of rest (10:2) or 4 min of rest (10:4), or 30 s work - 4 min of rest (30:4)] or a control group (CON). Participants underwent six training sessions over two weeks. Assessments consisted of a graded exercise test [maximal oxygen consumption (VO2peak) and peak power output (PPO)], four constant-work rate trials [critical power, anaerobic working capacity, and electromyographic fatigue threshold], and an upper body Wingate test (mean/peak power and total work). Post-training absolute and relative VO2peak was greater than pre-training for 30:4 (p = .005 and p = .009, respectively), but lower for CON (p = .001 and p = .006, respectively). Post-training PPO was greater in 30:4 (p < .001). No differences were observed during the constant-work rate trials or Wingate test. Traditional SIT appears to have enhanced VO2peak in the upper body over a short-term two-week intervention.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Critical power; Fatigue thresholds; Interval training; Peak power; Performance; Wingate

Mesh:

Year:  2019        PMID: 30660860     DOI: 10.1016/j.resp.2019.01.005

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  1 in total

1.  Alterations in energy system contribution following upper body sprint interval training.

Authors:  Michael B La Monica; David H Fukuda; Tristan M Starling-Smith; Nicolas W Clark; Valeria L G Panissa
Journal:  Eur J Appl Physiol       Date:  2020-01-23       Impact factor: 3.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.